The FDA granted orphan drug designation to CTD402 for relapsed or refractory T-cell acute lymphoblastic leukemia and ...

Real-World Data and Real-World Evidence (RWD/RWE) have been utilized not only for drug safety assessment but also for ...

Several medical societies supported extending Medicare coverage for TAVR to patients with asymptomatic aortic stenosis, but ...

Under earlier rules, drugmakers had to get a test licence from CDSCO to manufacture small quantities of drugs for research, ...

Nvidia is no longer content to be the chip supplier behind other companies’ biotech ambitions. With a multibillion dollar ...

Targeted protein degradation presents a promising strategy to address antimicrobial resistance, focusing on innovative ...

The global rise of antimicrobial resistance (AMR) among pathogenic microorganisms is widely recognised as one of the most pressing challenges in ...

Raises 2026 Financial Guidance Ranges: – Increases Total Revenue to $1,710 – $1,810 million, YoY Growth of 23% to 30%2 – ...

Papzimeos, an HPV-specific immunotherapy, is the first FDA-approved treatment for recurrent respiratory papillomatosis, ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

The change is expected to save at least 90 days in the drug development life cycle — a major boost for research timelines and ...

A paper published in Biology Methods and Protocols, indicates that a new computational method may help researchers identify ...